New management for the EUTOP Group

Share

Stefan Mappus is the new Managing Director of the EUTOP Group. Together with long-standing Managing Director Christian Schaufler, he will manage the fortunes of the Group from now on. Stefan Mappus is responsible for EUTOP's client business as a member of the management board and thus brings his wealth of experience in politics, administration and business directly to the benefit of EUTOP's clients.

Stefan Mappus / Copyright Image: Laurence Chaperon / Editorial use of this picture is free of charge. Please quote the source.
Stefan Mappus / Copyright Image: Laurence Chaperon / Editorial use of this picture is free of charge. Please quote the source.

After completing an apprenticeship as an industrial business manager at Standard Elektrik Lorenz AG and completing his military service, Stefan Mappus studied economics and social sciences at the University of Hohenheim, where he afterwards became a research assistant. After his election to the state parliament of Baden-Württemberg in 1996, he gave up his professional career in sales at Siemens AG and went into politics full-time. From 1998 to 2011, he was State Secretary, then Minister, CDU parliamentary group leader, State Chairman of the CDU Baden-Württemberg and finally Minister President of the State of Baden-Württemberg. Since 2012, after he left active politics, Stefan Mappus initially worked as an advisor to the Management Board of pmOne AG. Between 2015 and 2023, he was a member of the Management Board of pmOne AG and held the position of Group CFO from 2017 to 2023.

Prof Dr Klemens Joos, founder, shareholder and Chairman of the Advisory Board of the EUTOP Group, sees this appointment as the next step in EUTOP's special market positioning: "With the appointment of the former Minister President of Baden-Württemberg, the EUTOP Group is significantly strengthening its ability to continue to support its clients with excellence in the field of process-oriented political representation of interests."

Since 1990, the EUTOP Group - now with over 150 employees and structural advisors – has been supporting the work of interest groups of private companies, associations and organizations at the institutions of the European Union and selected EU member states as a structural process partner. In addition to the client's content competence, EUTOP provides the process structure competence, perspective change competence and process support competence that is now indispensable for successful representation of interests.

Enquiries & Contact:

Press department
EUTOP Group
+49 89 323700-0
eutop@eutop.eu

Location: Munich

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Dwinity IP GmbH: Nillion is pleased to announce that Dwinity, a team pioneering decentralized AI has joined as an ecosystem partner2.5.2024 09:38:30 CEST | Press release

With huge amounts of personal data being collected every day, privacy concerns are escalating as the impact of data breaches become more costly. The need to address the problems created by the existing data economy have never been greater. By empowering users to reclaim control, Dwinity aims to unlock an enormous amount of potential for personal data to enhance various industries like healthcare, insurance, and finance.

Nano-Care Deutschland AG launches next generation of sustainable PFAS-free oleophobic coatings29.4.2024 08:39:10 CEST | Press release

Nano-Care Deutschland AG, leader in the development of innovative surface finishes, is excited to announce the launch of its latest product range. Taking “next generation products” as its theme, the company is introducing a range of revolutionary solutions that not only offer maximum performance, but also place a strong emphasis on sustainability and environmental compatibility.

Additional partnership in medical technology: Bosch and R-Biopharm to strengthen Vivalytic analysis platform Plans to use innovative Bosch BioMEMS technology in PCR tests for multiresistant bacteria18.4.2024 10:15:00 CEST | Press release

Bosch and R-Biopharm are jointly investing 150 million euros in the development of new PCR tests and in marketing. PCR test for multiresistant gram-negative (MRGN) bacteria to be developed using novel BioMEMS technology. BioMEMS chips permit simultaneous testing of up to 250 genetic characteristics – in some cases, in less than 15 minutes. Darmstadt, Gerlingen, and Waiblingen, Germany – The market for medical technology is innovative, dynamic, and growing. Bosch sees medical technology as a strategic growth field and intends to expand its Bosch Healthcare Solutions subsidiary, based in Waiblingen. Bosch has now entered into a new partnership with the German diagnostics solutions company R-Biopharm. This partnership will be focused on Bosch’s universal, fully automated Vivalytic molecular diagnostic analysis platform. The two companies will invest a total of 150 million euros by the end of the decade. Within their strategic development and distribution partnership, the partners intend t

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye